Clinical Trials

Pancreatic Adenocarcinoma Locally Advanced

NCT03484299 2025-10-29

Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

Phase 1 Recruiting

Phase NA Not yet recruiting

Pancreatic Neoplasms

NCT07191548 2025-10-10

LIVERMET-IRE

50 enrolled

Phase NA Not yet recruiting

Carcinoma, Hepatocellular, Liver Diseases

NCT07192731 2025-10-10

LIVERHCC-IRE

50 enrolled

Carcinoma, Hepatocellular

NCT06205849 2025-07-25

Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer

Phase 1 Recruiting

18 enrolled

Pancreatic Neoplasms

NCT04276857 2025-05-13

SMART

Phase NA Recruiting

27 enrolled

Locally Advanced Pancreatic Cancer

NCT06185556 2024-08-23

COLDFIRE-III

Phase 2/3 Recruiting

78 enrolled

Phase 1/2 Not yet recruiting

Colorectal Neoplasms

NCT06047015 2024-08-09

Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer

12 enrolled

Liver Metastasis Colon Cancer

NCT03630640 2024-07-31

NIVOLEP

Phase 2 Completed

43 enrolled

Carcinoma, Hepatocellular

NCT05609656 2024-06-03

ELI

Phase 2 Terminated

4 enrolled

Colorectal Neoplasms

NCT05435053 2023-09-15

CHECKPOINT

Phase 2 Terminated

9 enrolled

Pancreatic Neoplasms

NCT01939665 2022-12-20

PANFIRE

50 enrolled

Pancreatic Neoplasms

NCT02082782 2022-12-20

COLDFIRE-2

Phase 2 Completed

51 enrolled

Colorectal Liver Metastases

NCT02791503 2022-12-20

CROSSFIRE

74 enrolled

Pancreatic Neoplasms

NCT04612530 2022-12-20

PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer

Phase 1 Unknown

18 enrolled

Pancreatic Neoplasms

NCT03257150 2022-08-11

A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer

12 enrolled

Pancreatic Ductal Adenocarcinoma

NCT04717687 2022-07-13

HOPE

Cholangiocarcinoma

NCT04835402 2022-03-09

EPIC-1

Phase 2 Unknown

8 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT02329106 2021-09-05

Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome

Liver Neoplasms

NCT02333773 2021-09-05

IRE

15 enrolled

Liver Neoplasms

NCT02425059 2021-09-05

Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms

Rectal Neoplasms

NCT02430636 2021-09-05

IRE

Stomach Neoplasms

NCT02430662 2021-09-05

IRE

Gallbladder Neoplasms

NCT02430701 2021-09-05

IRE

Esophageal Neoplasms

NCT03337997 2021-05-06

A Pilot Study of IRE for Resectable Pancreatic Cancer

Pancreatic Adenocarcinoma Resectable

NCT04093141 2021-04-01

CHEMOFIRE-2

Unresectable Pancreatic Cancer

NCT04404647 2021-03-26

Irreversible Electroporation of Unresectable Liver Tumors

Bile Duct Neoplasms, Carcinoma, Hepatocellular

NCT04816045 2021-03-25

Neoadjuvant Electrochemotherapy for Colorectal Cancer - a Randomized Controlled Trial

Phase 1/2 Unknown

24 enrolled

Colorectal Neoplasms

NCT02981719 2021-01-22

Simultaneous Gemcitabine and Irreversible Electroporation for Locally Advanced Pancreatic Cancer

61 enrolled

Pancreatic Neoplasms

NCT03040453 2020-11-30

IRAL

Carcinoma, Hepatocellular

NCT03180437 2020-11-02

Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer

62 enrolled

Pancreatic Neoplasms

NCT04139070 2020-08-20

Electrochemotherapy for Non-curable Gastric Cancer

Phase 1 Unknown

8 enrolled

Stomach Neoplasms

NCT03183219 2020-07-13

Safety and Efficiency of γδ T Cell Against Liver Cancer

Liver Neoplasms

NCT02828865 2020-07-07

A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers

18 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02841436 2020-07-07

A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer

7 enrolled

Pancreatic Neoplasms

NCT04310553 2020-03-17

An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined With Radiotherapy and Chemotherapy in Patients With Locally Advanced Pancreatic Cancer

240 enrolled

Pancreatic Neoplasms

NCT02718859 2019-09-12

Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer

60 enrolled

Pancreatic Neoplasms

NCT03008343 2019-09-12

Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer

Carcinoma, Hepatocellular

NCT02898649 2019-02-15

Safety and Efficacy of Irreversible Electroporation for Locally Advanced Pancreatic Cancer

100 enrolled

Locally Advanced Pancreatic Cancer

NCT03239184 2019-01-25

Bioinformation Therapy for Pancreatic Cancer

Phase 2/3 Completed

120 enrolled

Unresectable Pancreatic Cancer

NCT03350477 2019-01-25

Bioinformation Therapy for Gastric Cancer

Phase 2/3 Completed

120 enrolled

Advanced Gastric Cancer

NCT02010801 2013-12-13

Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01442324 2012-07-18

Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma

5 enrolled